Clean the area with the alcohol swab, using gentle outward circles about the size of a silver dollar
GLP-1 receptor agonists are licensed for type 2 diabetes and weight management, not specifically for cholesterol reduction
TodayiIt has gotten slightly larger (tennis ball)
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised semaglutide tablets for use in adults with obesity, or those who are overweight with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%